Signum Biosciences
Boulder · Founded 2004
About Signum Biosciences
Signum Biosciences is a private biotechnology company dedicated to developing small-molecule therapeutics derived from its Signal Transduction Modulation (STM) platform to modulate signal transduction imbalances. Through research on protein networks that control biological systems, Signum is developing therapeutic agents for several skin conditions, Alzheimer's, Parkinson's, asthma and COPD. Signum's STM technology provides many opportunities for the development of novel consumer products and pharmaceutical candidates.
Company Facts
- Founded: 2004
- Legal name: Signum Biosciences, Inc.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $5.6M
- Last round: Grant (Nov 2013)
- Website: signumbiosciences.com
- Phone: 7323298344
Social Profiles
Canonical: https://fsome.com/organization/signum-biosciences-8446776 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.